Valeant mulls three new directors, including one from Pershing Square: sources
 

Valeant mulls three new directors, including one from Pershing Square: sources
NEW YORK (Reuters) - Embattled drug company Valeant Pharmaceuticals, whose stock price has tumbled 38 percent this year, is mulling giving board seats to activist hedge fund Pershing Square Capital...http://feeds.feedburner.com/~ff/news...?d=yIl2AUoC8zA
[IMG]http://feeds.feedburner.com/~r/news/wealth/~4/Z***dkpgRZg[/IMG]